A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression
Crossref DOI link: https://doi.org/10.1007/s10549-016-4000-z
Published Online: 2016-10-05
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Reix, Nathalie http://orcid.org/0000-0003-0434-2895
Malina, Charlotte
Chenard, Marie-Pierre
Bellocq, Jean-Pierre
Delpous, Stéphanie
Molière, Sébastien
Sevrin, Anthony
Neuberger, Karl
Tomasetto, Catherine
Mathelin, Carole
License valid from 2016-10-05